These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 8706294)

  • 1. beta-cell function and glucose and lipid oxidation in Graves' disease.
    Bech K; Damsbo P; Eldrup E; Beck-Nielsen H; Røder ME; Hartling SG; Vølund A; Madsbad S
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):59-66. PubMed ID: 8706294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of glucose and lipid metabolism by continuous indirect calorimetry in Graves' disease: effect of an oral glucose load.
    Randin JP; Scazziga B; Jéquier E; Felber JP
    J Clin Endocrinol Metab; 1985 Dec; 61(6):1165-71. PubMed ID: 3840492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin sensitivity and exogenous insulin clearance in Graves' disease. Measurement by the glucose clamp technique and continuous indirect calorimetry.
    Randin JP; Tappy L; Scazziga B; Jequier E; Felber JP
    Diabetes; 1986 Feb; 35(2):178-81. PubMed ID: 3510924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence against a rate-limiting role of proinsulin processing for maximal insulin secretion in subjects with impaired glucose tolerance and beta-cell dysfunction.
    Stumvoll M; Fritsche A; Stefan N; Hardt E; Häring H
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1235-9. PubMed ID: 11238514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Insulin resistance in patients with Graves' disease and reduced glucose tolerance. The normalization of fasting insulin secretion in parallel with the restoration of thyroid function].
    Custro N; Scafidi V; Costanza G; Corsello FP
    Minerva Med; 1990; 81(7-8):523-7. PubMed ID: 2199851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of beta-cell function impairment in first-degree relatives of type 2 diabetic subjects: modeling analysis of 24-h triple-meal tests.
    Mari A; Gastaldelli A; Natali A; Ostergard T; Schmitz O; Ferrannini E
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E541-6. PubMed ID: 15522997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postexercise dose-response relationship between plasma glucose and insulin secretion.
    Mikines KJ; Farrell PA; Sonne B; Tronier B; Galbo H
    J Appl Physiol (1985); 1988 Mar; 64(3):988-99. PubMed ID: 3284873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
    Festa A; Williams K; Hanley AJ; Haffner SM
    Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
    Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
    Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired pancreatic alpha-cell response in hyperthyroidism.
    Kabadi UM; Eisenstein AB
    J Clin Endocrinol Metab; 1980 Sep; 51(3):478-82. PubMed ID: 6997327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A higher proinsulin response to glucose loading predicts deteriorating fasting plasma glucose and worsening to diabetes in subjects with impaired glucose tolerance.
    Inoue I; Takahashi K; Katayama S; Harada Y; Negishi K; Ishii J; Shibazaki S; Nagai M; Kawazu S
    Diabet Med; 1996 Apr; 13(4):330-6. PubMed ID: 9162608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucagon-like peptide 1 improves the ability of the beta-cell to sense and respond to glucose in subjects with impaired glucose tolerance.
    Byrne MM; Gliem K; Wank U; Arnold R; Katschinski M; Polonsky KS; Göke B
    Diabetes; 1998 Aug; 47(8):1259-65. PubMed ID: 9703326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance.
    Larsson H; Ahrén B
    Diabetes Care; 2000 May; 23(5):650-7. PubMed ID: 10834425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of beta-cell dysfunction in impaired glucose tolerance and diabetes.
    Polonsky KS
    Exp Clin Endocrinol Diabetes; 1999; 107 Suppl 4():S124-7. PubMed ID: 10522836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basal and glucose- and arginine-stimulated serum concentrations of insulin, C-peptide, and glucagon in hyperthyroid patients.
    Roti E; Braverman LE; Robuschi G; Salvi M; Gardini E; d'Amato L; Maestri D; Montermini M; Borciani E; Pezzarossa A
    Metabolism; 1986 Apr; 35(4):337-42. PubMed ID: 3515118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a deficient pancreatic beta-cell response in a rat model of hyperthyroidism.
    Fukuchi M; Shimabukuro M; Shimajiri Y; Oshiro Y; Higa M; Akamine H; Komiya I; Takasu N
    Life Sci; 2002 Jul; 71(9):1059-70. PubMed ID: 12088765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.
    Bock G; Dalla Man C; Campioni M; Chittilapilly E; Basu R; Toffolo G; Cobelli C; Rizza R
    Diabetes; 2006 Dec; 55(12):3536-49. PubMed ID: 17130502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.
    Behrens G; Dejam A; Schmidt H; Balks HJ; Brabant G; Körner T; Stoll M; Schmidt RE
    AIDS; 1999 Jul; 13(10):F63-70. PubMed ID: 10416516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
    Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.